These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23945174)

  • 1. Pharmacoeconomics of anterior ocular inflammatory disease.
    Bielory L; Syed BA
    Curr Opin Allergy Clin Immunol; 2013 Oct; 13(5):537-42. PubMed ID: 23945174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current market trends in anterior ocular inflammatory disease landscape.
    Khan RS; Rizvi S; Syed BA; Bielory L
    Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):503-509. PubMed ID: 31232860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current options and emerging therapies for anterior ocular inflammatory disease.
    Syed BA; Kumar S; Bielory L
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):485-9. PubMed ID: 25102104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations in the pharmacoeconomics of dry eye.
    Hirsch JD
    Manag Care; 2003 Dec; 12(12 Suppl):33-8. PubMed ID: 14723112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging therapies in allergic conjunctivitis and dry eye syndrome.
    Nye M; Rudner S; Bielory L
    Expert Opin Pharmacother; 2013 Aug; 14(11):1449-65. PubMed ID: 23822862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapeutics for ocular surface disease.
    Bielory BP; Shah SP; O'Brien TP; Perez VL; Bielory L
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):477-86. PubMed ID: 27585059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of dry eye: a conceptual framework and preliminary assessment.
    Reddy P; Grad O; Rajagopalan K
    Cornea; 2004 Nov; 23(8):751-61. PubMed ID: 15502474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United States cost-effectiveness study of two dry eye ophthalmic lubricants.
    Wlodarczyk J; Fairchild C
    Ophthalmic Epidemiol; 2009; 16(1):22-30. PubMed ID: 19191178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ocular inflammatory conditions with loteprednol etabonate.
    Pavesio CE; Decory HH
    Br J Ophthalmol; 2008 Apr; 92(4):455-9. PubMed ID: 18245274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed care implications of age-related ocular conditions.
    Cardarelli WJ; Smith RA
    Am J Manag Care; 2013 May; 19(5 Suppl):S85-91. PubMed ID: 23725500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of dry eye disease in the United States: a decision tree analysis.
    Yu J; Asche CV; Fairchild CJ
    Cornea; 2011 Apr; 30(4):379-87. PubMed ID: 21045640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic complications with laser-assisted in-situ keratomileusis.
    Bielory BP; O'Brien TP
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):483-91. PubMed ID: 21822133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry eye syndrome: an update in office management.
    Yao W; Davidson RS; Durairaj VD; Gelston CD
    Am J Med; 2011 Nov; 124(11):1016-8. PubMed ID: 21944160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, burden, and pharmacoeconomics of dry eye disease.
    Pflugfelder SC
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S102-6. PubMed ID: 18452369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry eyes: etiology and management.
    Latkany R
    Curr Opin Ophthalmol; 2008 Jul; 19(4):287-91. PubMed ID: 18545008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical treatment algorithm for managing ocular surface and tear disorders.
    Tseng SC
    Cornea; 2011 Oct; 30 Suppl 1():S8-S14. PubMed ID: 21912234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathology of the ocular surface].
    Pisella PJ
    Rev Prat; 2006 Jun; 56(11):1226-31. PubMed ID: 16903523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomics of subcutaneous allergen immunotherapy.
    Incorvaia C; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Ciprandi G; D'Anneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():17-20. PubMed ID: 18924462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomics and macular degeneration.
    Brown GC; Brown MM; Brown H; Godshalk AN
    Curr Opin Ophthalmol; 2007 May; 18(3):206-11. PubMed ID: 17435427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.